Complement C3 inhibition in severe COVID-19 using compstatin AMY-101

Skendros, P., Germanidis, G., Mastellos, D. C., Antoniadou, C., Gavriilidis, E., Kalopitas, G., Samakidou, A., Liontos, A., Chrysanthopoulou, A., Ntinopoulou, M., Kogias, D., Karanika, I., Smyrlis, A., Cepaityte, D., Fotiadou, I., Zioga, N., Mitroulis, I., Gatselis, N. K., Papagoras, C., … Lambris, J. D. (2022). Complement C3 inhibition in severe COVID-19 using compstatin AMY-101. Science Advances, 8(33). https://doi.org/10.1126/sciadv.abo2341
Authors:
Panagiotis Skendros
Christina Antoniadou
Efstratios Gavriilidis
Akrivi Chrysanthopoulou
Maria Ntinopoulou
Dionysios Kogias
Andreas Smyrlis
Iliana Fotiadou
Nikoleta Zioga
Ioannis Mitroulis
Charalampos Papagoras
Vasileios Papadopoulos
Konstantinos Ritis
Georgios Germanidis
Georgios Kalopitas
Ioanna Karanika
Dainora Cepaityte
Simeon Metallidis
Dimitrios C. Mastellos
Anna Samakidou
Nikolaos K. Gatselis
George N. Dalekos
Angelos Liontos
Haralampos Milionis
Loek Willems
Barbro Persson
Vivek Anand Manivel
Bo Nilsson
E. Sander Connolly
Simona Iacobelli
Rodrigo T. Calado
Markus Huber-Lang
Antonio M. Risitano
Despina Yancopoulou
John D. Lambris
Affiliated Authors:
E. Sander Connolly
Columbia Affiliation:
elink
Publication Type:
Article
Unique ID:
10.1126/sciadv.abo2341
PMID:
35977025
DOI:
10.1126/sciadv.abo2341
Journal:
Science Advances
Publication Date:
Data Source:
Web of Science
Source Link:
View Web of Science Record

Record Created: